One little piglet was born with only one large eye. A second piglet was missing an ear. A third piglet had a large hole in its skull. A fourth piglet had a monstrously huge "elephant tongue." A female piglet was born with testes. Still others had malformed limbs, spines, skulls and gastrointestinal tracts.

The pigs in question belonged to a Danish pig farmer. For three years he had fed his pigs ordinary, non-genetically modified soy. When he ran out, he bought the cheaper genetically modified (GM) soy pig feed. His herdsman, unaware of the feed switch, immediately noticed that the pigs lost their appetite and that the piglets developed diarrhea. Even worse was the sudden and shocking increase in birth defects. The farmer, eager to understand the cause, had 38 of the deformed pigs euthanized and tested for glyphosate, the herbicide used on the GM soy. The results were published in the April 2014 issue of the Journal of Environmental and Analytic Toxicology. The samples of lung, liver, kidney, brain, gut wall, heart and muscle all tested positive.

If you haven't visited a chiropractor before, you might be missing out. Millions of people around the world have experienced the incredible benefits of chiropractic care.

One of the best things about chiropractic care, is that it is a drug-free and surgery-free path to healing naturally.

People have reported chiropractic benefits help to improve:

• Back pain
• Headaches
• Ear infections
• Neck pain
• Arthritis and joint pain
• Scoliosis
• Asthma
• Blood pressure
• Healthy pregnancy
• Organ function
• Surgery prevention

There are a lot of misconceptions about chiropractic and how chiropractors are trained. In fact, did you know many chiropractic programs also incorporate an entire year of PhD level advanced nutrition training?

However, most of the benefits of seeing a chiropractor come from getting a chiropractic adjustment. Let's talk about the philosophy, history and evidence-based research of chiropractic care.

Asia's dependency on rice cultivation for both subsidence and income is intuitively understood. The Food and Agricultural Organization of the United Nations (FAO) estimates the agricultural population of lowland rice cultivation in Asia to be over 470 million - larger than the entire population of the United States. Improvements in rice cultivation would stand to lift hundreds of millions from debt and poverty. Conversely, the disruption of rice cultivation would threaten to mire hundreds of millions in deeper debt, inescapable destitution, and all of the negative socioeconomic implications that follow.

Asia's rice farmers produce between 1-2 harvests a year depending on the climb and climate of any given region. They do so to sell their rice, generally to mills who in turn sell the final product to exporters or for domestic consumption. Out of each harvest, rice farmers keep a portion for their own consumption, but the vast majority of what they grow is for income.

The UK-based Rice Association claims there are up to 40,000 species of rice, with a wide variety of characteristics suitable for different markets and uses. Rice farmers grow those which local, national and regional markets are best suited to move. In nations where subsidies are offered for rice crops, cheap, easy to grow varieties are chosen. More desirable or exotic species are grown by independent farmers who have developed their own cooperative with millers, marketers and exporters. The rice Asians eat depends on both economic and market realities. The impoverished eat what is cheapest and most easily available, but not necessarily that which is healthiest.

The number of heart attacks in the UK is 50,000 higher than previously thought, according to figures from the British Heart Foundation.

The charity said numbers are 35% higher than estimates have suggested, with around 175,000 heart attacks thought to take place each year.

The figures translate to one person having a heart attack every three minutes, the charity said.

While Ebola, the deadly disease spreading through parts of West Africa, has no cure, specific treatment or vaccine, there are several experimental drugs being tested in US labs. Now the FDA has lifted its hold on one of those drugs.

The US Food and Drug Administration gave Tekmira Pharmaceuticals verbal confirmation that they modified the full clinical hold the regulatory agency had placed on the company's experimental TKM-Ebola drug, enabling the potential use on Ebola patients, Tekmira said in a statement.

"We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so," said Dr. Mark Murray, CEO and president of Tekmira.

"This current outbreak underscores the critical need for effective therapeutic agents to treat the Ebola virus. We recognize the heightened urgency of this situation, and are carefully evaluating options for use of our investigational drug within accepted clinical and regulatory protocols."

The company, in collaboration with infectious disease researchers from Boston University and the United States Army Medical Research Institute for Infectious Diseases, showed the drug's ability to protect non-human primates from Ebola in preclinical trials in May 2010, Tekmira said.

A Phase I clinical trial ‒ the first step towards FDA approval ‒ began on humans in January. The agency then approved a fast-track designation for the drug in March, around the same time the Ebola outbreak began in Guinea, Liberia and Sierra Leone. It has since spread to Nigeria. According to World Health Organization figures published on Wednesday, there are over 1,700 suspected and confirmed cases of Ebola in the four countries, and 932 of those patients have died from the disease.

A different drug, ZMapp by Mapp Biopharmaceutical Inc., was used to treat two American aid workers who had contracted Ebola in Liberia. ZMapp, previously only known as "a secret serum," has not been given the go-ahead to begin human trials yet, Forbes reported. It works by boosting the immune system to battle against Ebola. The treatment consists of antibodies from lab animals exposed to the virus.

Cognitive abilities such as memory and attention are not only important after a stroke but also before; according to Declining memory and cognitive ability may increase the risk of stroke in adults over age 65. After stroke, cognitive function declined almost twice as fast. Stroke and cognitive decline increased the risk of death in older adults.

Research published in the American Heart Association journal Stroke.

Previous studies have shown poor cardiovascular health can increase the risk of cognitive impairment such as problems in memory and learning. However, the opposite idea that cognitive impairment may impact cardiovascular health, specifically stroke, was not established before.

Doctors on the French Riviera have treated 17 people for dengue fever and chikungunya this year, amid fears that a decade-long invasion of Asian tiger mosquitoes in the region could spread the tropical diseases.

All of the infected patients had visited Brazil, where they went to see the Football World Cup, and the Caribbean. Four of them had dengue fever and 11 contracted chikungunya. Two unlucky victims came back infected with both.

The presence of Asian tiger mosquitoes in France is proving a big concern to health services because unlike native species they are able to transmit both dengue and chikungunya. The Asian tiger mosquito, which has distinctive black and white stripes, was introduced to Europe in the late 1970s via a goods shipment from China to Albania.

A subsequent introduction in Italy in the 1990s, thought to be from larvae in a delivery of car tires from the USA, led to a population explosion in Italy which gradually spread.

First seen in France in 2004, the mosquitoes have now firmly established themselves along France's Mediterranean coast and are moving up the Rhône valley. In 2010, two cases of Dengue were contracted in the Riviera after mosquito bites in France itself, a nightmare scenario for local health services.

The response in the Alpes-Maritimes administrative region is aggressive.

In some cases, powerful insecticides are used to drench a 500 metre radius around the infected person to kill all mosquitoes and so guarantee the disease does not spread, according to local daily Nice Matin.

"More than that isn't really necessary," Dr Fabien Josserand of the regional council told the newspaper. "Asian tiger mosquitoes do not spread fast and rarely if ever fly more than 100 metres from where they hatch."

An estimated 400,000 French tourists visit regions with dengue fever and chikungunya every year.

The plague isn't here, yet. But there are many signs that some form of pandemic is imminent.

As the death toll rises in West Africa amid the worst Ebola outbreak on record, a separate threat is compounding the problem: the rainy season and the malaria that comes with it.

In Sierra Leone, with the most Ebola cases in the epidemic, a fearful population is failing to seek medical attention for any diseases, health officials say. If they have malaria, the feeling is they don't want to go near a hospital with Ebola cases. If it's Ebola, they don't believe the hospitals can help them anyway, instead turning to traditional healers.

It's a widening challenge complicated by the fact that Ebola, malaria and cholera share common symptoms early on, including fever and vomiting, which can cause confusion among patients, said Cyprien Fabre, head of the West Africa office of the European Commission's humanitarian aid department.

"We now have increased mortality for these other diseases" as well, Fabre said by telephone from Freetown, the country's capital, after visiting Ebola treatment centers in Kenema and Kailahun near the eastern border. "This is a slow-motion disaster."

The issue threatens to further undermine health and welfare in Sierra Leone, which has the world's highest rate of child and maternal mortality, Fabre said.

The outbreak has killed 932 people in Guinea, Liberia and Sierra Leone since it was first reported in March, according to the World Health Organization. That includes 45 deaths from Aug. 2 to Aug. 4, the health group said.

The Nigerian government on Wednesday described the Ebola outbreak in the country as a national emergency.

Minister of Health Onyebuchi Chukwu said this at an emergency meeting convened by the House of Representatives Committee on Health over the Ebola outbreak in Abuja, the nation's capital city.

He said out of six Nigerians diagnosed with Ebola virus, one had died on Tuesday, adding that the other five patients were receiving treatment.